Gan & Lee Pharmaceuticals. (SHA:603087)

SHA:603087 Revenue

Gan & Lee Pharmaceuticals. had revenue of 1.08B CNY in the quarter ending June 30, 2025, with 43.39% growth. This brings the company's revenue in the last twelve months to 3.80B, up 41.00% year-over-year. In the year 2024, Gan & Lee Pharmaceuticals. had annual revenue of 3.05B with 16.77% growth.

• Revenue (ttm): 3.80B
• Revenue Growth: +41.00%
• P/S Ratio: 10.79
• Revenue / Employee: 723.98K
• Employees: 5,245
• Market Cap: 40.97B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.05B	437.31M	16.77%
Dec 31, 2023	2.61B	895.77M	52.31%
Dec 31, 2022	1.71B	-1.90B	-52.60%
Dec 31, 2021	3.61B	250.16M	7.44%
Dec 31, 2020	3.36B	466.82M	16.12%